Umoja Biopharma and TreeFrog Therapeutics announce collaboration to address current challenges facing ex vivo allogeneic therapies in immuno-oncology June 10, 2022
TreeFrog Therapeutics expands Board with new independent members from the cell therapy industry April 14, 2022
TreeFrog Therapeutics opens technological hub in Kobe, Japan, to drive partnerships opportunities in the field of iPSC-derived cell therapies April 8, 2022
EIC ScalingUp TOP50: TreeFrog Therapeutics selected among 3,000 European Deeptech companies April 1, 2022
TreeFrog Therapeutics appoints Scientific Advisory Board to guide the development of proprietary iPS platform & cell therapy pipeline March 1, 2022
